Insider Transactions Reported by 14 Insiders of
EKSO BIONICS HOLDINGS, INC.
-
Symbol
-
EKSO on Nasdaq
-
Location
-
San Rafael, CA
Quick Takeaways
- EKSO - EKSO BIONICS HOLDINGS, INC. has 14 insiders with reported activity on this page.
- Net insider value flow over the last year: +$971,689.
- Recent transaction rows are available for direct filing-level review.
What Changed
- Buy value: $1,203,751; sell value: $232,062.
- Net share flow: <span class="text-green-600">+74,231</span>.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Filed on Form 4
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Insiders trading volume in the past year
Insider trading buckets (0-12 months)
EKSO BIONICS HOLDINGS, INC. executives and other stock owners filed with the SEC include:
| Name |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Valuation |
Report Date |
| Daniel Asher |
10%+ Owner |
$7,697,527 |
+$1,172,752 |
+18% |
Mixed |
19 Feb 2026 |
| Steven Sherman |
Executive Chair |
$447,177 |
|
|
Mixed |
08 Jun 2023 |
| Scott G. Davis |
CEO, Director |
$380,042 |
-$111,912 |
-23% |
Mixed |
10 Nov 2025 |
| Jason C. Jones |
Chief Operating Officer |
$338,650 |
-$44,650 |
-12% |
Mixed |
16 Mar 2026 |
| Jerome Wong |
Chief Financial Officer |
$326,024 |
-$44,501 |
-12% |
Mixed |
16 Mar 2026 |
| Corinna Lathan |
Director |
$186,350 |
|
|
Mixed |
16 May 2025 |
| Kecheng Li |
Director |
$185,758 |
|
|
Mixed |
16 May 2025 |
| Mary Ann Cloyd |
Director |
$184,052 |
|
|
Mixed |
16 May 2025 |
| Stanley Stern |
Director |
$166,273 |
|
|
Mixed |
04 Dec 2022 |
| Jack Peurach |
President & CEO, Director |
$145,499 |
|
|
Mixed |
31 Aug 2021 |
| Rhonda A. Wallen |
Director |
$141,662 |
|
|
Mixed |
08 Jun 2023 |
| Deborah Lafer Scher |
Director |
$126,710 |
|
|
Mixed |
16 May 2025 |
| William R. Shaw |
Chief Commercial Officer |
$96,516 |
|
|
Mixed |
17 Feb 2022 |
| John Glenn |
Chief Financial Officer |
$34,975 |
|
|
Mixed |
22 Mar 2022 |
Recent Insider Transactions by Companies or Individuals for EKSO BIONICS HOLDINGS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider |
Symbol |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares Owned |
Date |
Ownership |
| Jason C. Jones |
EKSO |
Common Stock |
Purchase |
41.6% |
$15,500 |
$11.85 |
1,308 |
4,449 |
16 Mar 2026 |
By 401(k) |
| Jerome Wong |
EKSO |
Common Stock |
Purchase |
45.5% |
$15,500 |
$11.85 |
1,308 |
4,184 |
16 Mar 2026 |
By 401(k) |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
6.1% |
$191,162 |
$12.30 |
15,540 |
270,432 |
19 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
0.46% |
$11,520 |
$9.60 |
1,200 |
259,992 |
19 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
11.7% |
$245,687 |
$9.04 |
27,192 |
258,792 |
13 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
20.3% |
$373,656 |
$9.57 |
39,032 |
231,600 |
12 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
12% |
$199,770 |
$9.69 |
20,611 |
192,568 |
11 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
6.31% |
$101,225 |
$9.92 |
10,200 |
171,957 |
10 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
3.06% |
$47,820 |
$9.96 |
4,800 |
161,757 |
09 Feb 2026 |
by DBA Trading, LLC |
| Daniel Asher |
EKSO |
Common Stock |
Purchase |
0.12% |
$1,912 |
$9.86 |
194 |
156,957 |
06 Feb 2026 |
by DBA Trading, LLC |
| Jason C. Jones |
EKSO |
Common Stock |
Sale |
-4.9% |
$12,210 |
$9.25 |
-1,320 |
25,621 |
06 Jan 2026 |
Direct |
| Jason C. Jones |
EKSO |
Common Stock |
Sale |
-0.99% |
$1,269 |
$4.70 |
-270 |
26,941 |
09 Dec 2025 |
Direct |
| Jerome Wong |
EKSO |
Common Stock |
Sale |
-4.76% |
$5,819 |
$4.70 |
-1,238 |
24,771 |
09 Dec 2025 |
Direct |
| Jerome Wong |
EKSO |
Common Stock |
Sale |
-30.3% |
$54,182 |
$4.80 |
-11,288 |
26,009 |
10 Nov 2025 |
Direct |
| Jason C. Jones |
EKSO |
Common Stock |
Sale |
-26.3% |
$46,670 |
$4.80 |
-9,723 |
27,211 |
10 Nov 2025 |
Direct |
| Scott G. Davis |
EKSO |
Common Stock |
Sale |
-22.8% |
$111,912 |
$4.80 |
-23,315 |
78,777 |
10 Nov 2025 |
Direct |
| Scott G. Davis |
EKSO |
Common Stock |
Award |
362.1% |
|
|
80,000 |
102,092 |
05 Nov 2025 |
Direct |
| Jason C. Jones |
EKSO |
Common Stock |
Award |
68.4% |
|
|
15,000 |
36,934 |
05 Nov 2025 |
Direct |
| Jerome Wong |
EKSO |
Common Stock |
Award |
109.6% |
|
|
19,500 |
37,297 |
05 Nov 2025 |
Direct |
| Mary Ann Cloyd |
EKSO |
Common Stock |
Award |
107.1% |
|
|
236,202 |
456,707 |
16 May 2025 |
Direct |
| Corinna Lathan |
EKSO |
Common Stock |
Award |
104.4% |
|
|
236,202 |
462,409 |
16 May 2025 |
Direct |
| Kecheng Li |
EKSO |
Common Stock |
Award |
105.1% |
|
|
236,202 |
460,940 |
16 May 2025 |
Direct |
| Deborah Lafer Scher |
EKSO |
Common Stock |
Award |
302% |
|
|
236,202 |
314,419 |
16 May 2025 |
Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.